BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11408359)

  • 1. Selective dehydrogenation/oxygenation of 3-methylindole by cytochrome p450 enzymes.
    Lanza DL; Yost GS
    Drug Metab Dispos; 2001 Jul; 29(7):950-3. PubMed ID: 11408359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of 3-methylindole by vaccinia-expressed P450 enzymes: correlation of 3-methyleneindolenine formation and protein-binding.
    Thornton-Manning J; Appleton ML; Gonzalez FJ; Yost GS
    J Pharmacol Exp Ther; 1996 Jan; 276(1):21-9. PubMed ID: 8558432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic studies on the cytochrome P450-catalyzed dehydrogenation of 3-methylindole.
    Skiles GL; Yost GS
    Chem Res Toxicol; 1996; 9(1):291-7. PubMed ID: 8924606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific dehydrogenation of 3-methylindole and epoxidation of naphthalene by recombinant human CYP2F1 expressed in lymphoblastoid cells.
    Lanza DL; Code E; Crespi CL; Gonzalez FJ; Yost GS
    Drug Metab Dispos; 1999 Jul; 27(7):798-803. PubMed ID: 10383923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single mutations change CYP2F3 from a dehydrogenase of 3-methylindole to an oxygenase.
    Kartha JS; Skordos KW; Sun H; Hall C; Easterwood LM; Reilly CA; Johnson EF; Yost GS
    Biochemistry; 2008 Sep; 47(37):9756-70. PubMed ID: 18717595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism and bioactivation of 3-methylindole by human liver microsomes.
    Yan Z; Easterwood LM; Maher N; Torres R; Huebert N; Yost GS
    Chem Res Toxicol; 2007 Jan; 20(1):140-8. PubMed ID: 17226936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary bioactivation of trichloroethylene to chloral hydrate: relative contributions of CYP2E1, CYP2F, and CYP2B1.
    Forkert PG; Baldwin RM; Millen B; Lash LH; Putt DA; Shultz MA; Collins KS
    Drug Metab Dispos; 2005 Oct; 33(10):1429-37. PubMed ID: 15987776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of polymorphic human cytochrome P450 enzymes in estrone oxidation.
    Cribb AE; Knight MJ; Dryer D; Guernsey J; Hender K; Tesch M; Saleh TM
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):551-8. PubMed ID: 16537715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning and expression of CYP2F3, a cytochrome P450 that bioactivates the selective pneumotoxins 3-methylindole and naphthalene.
    Wang H; Lanza DL; Yost GS
    Arch Biochem Biophys; 1998 Jan; 349(2):329-40. PubMed ID: 9448722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative metabolism of the alkaloid rutaecarpine by human cytochrome P450.
    Ueng YF; Don MJ; Jan WC; Wang SY; Ho LK; Chen CF
    Drug Metab Dispos; 2006 May; 34(5):821-7. PubMed ID: 16501007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel cytochrome P450 enzyme responsible for the metabolism of ebastine in monkey small intestine.
    Hashizume T; Mise M; Matsumoto S; Terauchi Y; Fujii T; Imaoka S; Funae Y; Kamataki T; Miyazaki H
    Drug Metab Dispos; 2001 Jun; 29(6):798-805. PubMed ID: 11353747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism-based inactivation of lung-selective cytochrome P450 CYP2F enzymes.
    Kartha JS; Yost GS
    Drug Metab Dispos; 2008 Jan; 36(1):155-62. PubMed ID: 17962375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles of different porcine cytochrome P450 enzymes and cytochrome b5A in skatole metabolism.
    Wiercinska P; Lou Y; Squires EJ
    Animal; 2012 May; 6(5):834-45. PubMed ID: 22558931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A proton-shuttle mechanism mediated by the porphyrin in benzene hydroxylation by cytochrome p450 enzymes.
    de Visser SP; Shaik S
    J Am Chem Soc; 2003 Jun; 125(24):7413-24. PubMed ID: 12797816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porcine CYP2A19, CYP2E1 and CYP1A2 forms are responsible for skatole biotransformation in the reconstituted system.
    Matal J; Matuskova Z; Tunkova A; Anzenbacherova E; Anzenbacher P
    Neuro Endocrinol Lett; 2009; 30 Suppl 1():36-40. PubMed ID: 20027142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence supporting the formation of 2,3-epoxy-3-methylindoline: a reactive intermediate of the pneumotoxin 3-methylindole.
    Skordos KW; Skiles GL; Laycock JD; Lanza DL; Yost GS
    Chem Res Toxicol; 1998 Jul; 11(7):741-9. PubMed ID: 9671536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of porphyrin ligands on the regioselective dehydrogenation versus epoxidation of olefins by oxoiron(IV) mimics of cytochrome P450.
    Kumar D; Tahsini L; de Visser SP; Kang HY; Kim SJ; Nam W
    J Phys Chem A; 2009 Oct; 113(43):11713-22. PubMed ID: 19658379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-Methylindole metabolites induce lung CYP1A1 and CYP2F1 enzymes by AhR and non-AhR mechanisms, respectively.
    Weems JM; Yost GS
    Chem Res Toxicol; 2010 Mar; 23(3):696-704. PubMed ID: 20187624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of human and cynomolgus monkey cytochrome P450 2E1 enzymes.
    Hanioka N; Yamamoto M; Iwabu H; Jinno H; Tanaka-Kagawa T; Naito S; Shimizu T; Masuda K; Katsu T; Narimatsu S
    Life Sci; 2007 Oct; 81(19-20):1436-45. PubMed ID: 17935737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of pulmonary CYP4B2, specific catalyst of methyl oxidation of 3-methylindole.
    Carr BA; Ramakanth S; Dannan GA; Yost GS
    Mol Pharmacol; 2003 May; 63(5):1137-47. PubMed ID: 12695542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.